Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (21509, 12182, 18603)
Università degli Studi di Verona (RF-2016-02361940)
Qatar National Research Fund (NPRP11S-1211-170086)
Cancer reseacrh Institute (CLIP_2017)
Euronanomed III (Joint Translational Call_2017)
Cariverona Fondation (Project Call_2017)
Text and Data Mining valid from 2019-09-18
Received: 12 June 2019
Accepted: 5 September 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: Informed consent was obtained from all participants and the study was approved by the Ethics Committee: for the use of PDAC and HD PBMCs, Prot. 25978, Prog. 2172 on 29/05/2012 from Comitato Etico per la sperimentazione clinica delle province di Verona e Rovigo, principal investigator: Aldo Scarpa; for the use of Lin<sup>−</sup> cells from fresh BM aspirate samples Prot. 2014/101 on 15/12/2014 from Comitato Etico per la sperimentazione clinica della provincia di Padova principal investigator: Susanna Mandruzzato; for the use of PBMCs isolated from buffy coats Prot. 24114 on 16/05/2017 from Comitato Etico per la sperimentazione clinica delle province di Verona e Rovigo, principal investigator: Vincenzo Bronte.
: Not applicable.
: The authors declare that they have no competing interests.